» Articles » PMID: 7138600

The 1982 Revised Criteria for the Classification of Systemic Lupus Erythematosus

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 1982 Nov 1
PMID 7138600
Citations 3464
Authors
Affiliations
Soon will be listed here.
Abstract

The 1971 preliminary criteria for the classification of systemic lupus erythematosus (SLE) were revised and updated to incorporate new immunologic knowledge and improve disease classification. The 1982 revised criteria include fluorescence antinuclear antibody and antibody to native DNA and Sm antigen. Some criteria involving the same organ systems were aggregated into single criteria. Raynaud's phenomenon and alopecia were not included in the 1982 revised criteria because of low sensitivity and specificity. The new criteria were 96% sensitive and 96% specific when tested with SLE and control patient data gathered from 18 participating clinics. When compared with the 1971 criteria, the 1982 revised criteria showed gains in sensitivity and specificity.

Citing Articles

Systematic review of the reporting of extrarenal manifestations in observational studies of Saudi patients with systemic lupus erythematosus.

Alenzi F, Aljohani R, Aboabat A, Alanazi F, Almalag H, Omair M Lupus Sci Med. 2025; 12(1).

PMID: 40044501 PMC: 11883561. DOI: 10.1136/lupus-2024-001469.


Pleuropulmonary Involvement in Patients with Systemic Lupus Erythematosus as Detected by High-Resolution CT Scans: Clinical and Immunological Association.

Hasan M, Alismail M, Bokhari D, Alghamdi R, Alhalal Z, Alqatari S Medicina (Kaunas). 2025; 61(2).

PMID: 40005299 PMC: 11857599. DOI: 10.3390/medicina61020181.


Why is it so difficult to understand why we don't understand human systemic lupus erythematosus? Contemplating facts, conflicts, and impact of "the causality cascade paradigm".

Rekvig O Front Immunol. 2025; 15:1507792.

PMID: 39936150 PMC: 11811100. DOI: 10.3389/fimmu.2024.1507792.


Rare and common single nucleotide variants in childhood-onset systemic lupus erythematosus.

Sayadi A, Sandling J, Eloranta M, Jonsen A, Gunnarsson I, Rantapaa-Dahlqvist S Lupus Sci Med. 2025; 12(1).

PMID: 39933823 PMC: 11815458. DOI: 10.1136/lupus-2024-001436.


Comparative efficacy and safety of different recommended doses of telitacicept in patients with systemic lupus erythematosus in China: a systematic review and meta-analysis.

Gao S, Yang C, Huang B, Yang L, Lu L, Yang H Front Immunol. 2025; 15:1472292.

PMID: 39867893 PMC: 11757125. DOI: 10.3389/fimmu.2024.1472292.